How to buy Allergy Therapeutics (AGY) shares

Learn how to easily invest in Allergy Therapeutics shares.

Allergy Therapeutics (AGY) is a publicly traded drug manufacturers-specialty and generic business based in the UK. It opened the day at 25.22p after a previous close of 25.25p. During the day the price has varied from a low of 25p to a high of 25.5p. The latest price was 25.25p (25 minute delay). Allergy Therapeutics is listed on the London Stock Exchange (LSE) and employs 600 staff. All prices are listed in pence sterling.

How to buy shares in Allergy Therapeutics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: AGY in this case.
  5. Research Allergy Therapeutics shares. The platform should provide the latest information available.
  6. Buy your Allergy Therapeutics shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 500x Allergy Therapeutics shares with popular platforms

Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £0.00
£126.25 total
Capital at risk
IG Share Dealing logo £0 £250 £8.00
£134.25 total
Capital at risk
Fineco logo £0 No minimum £0.00
£126.25 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £11.95
£138.20 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.77
£128.02 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £7.99
£134.24 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £9.50
£135.75 total
Capital at risk

Full comparison of share dealing platforms

Allergy Therapeutics share price (LSE:AGY)

Use our graph to track the performance of AGY stocks over time.

Allergy Therapeutics price performance over time

Historical closes compared with the last close of 25.25p

1 week (2022-09-27) 36.49%
1 month (2022-09-02) 29.49%
3 months (2022-07-04) 29.49%
6 months (2022-04-04) -2.88%
1 year (2021-10-04) -32.67%
2 years (2020-10-02) 65.57%
3 years (2019-10-04) 106.12%
5 years (2017-10-04) -22.31%

Is it a good time to buy Allergy Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
IG bxs hero

Invest in Allergy Therapeutics shares with IG

  • No commission on US shares
  • More than 13,000 shares to invest in
  • Open your account in minutes

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Allergy Therapeutics shares at a glance

Information last updated 2021-07-09.
Open25.22p
High25.5p
Low25p
Close25.25p
Previous close25.25p
Change0p
Change %0%
Volume208,370
Information last updated 2022-10-03.
52-week range15.25p - 40.5p
50-day moving average19.195p
200-day moving average22.746p
Wall St. target price65p
Dividend yield0p (0%)
Earnings per share (TTM)-0.8p

Allergy Therapeutics share dividends

We're not expecting Allergy Therapeutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, Allergy Therapeutics's shares have ranged in value from as little as 15.25p up to 40.5p. A popular way to gauge a stock's volatility is its "beta".

AGY.LSE volatility(beta: 1.4)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Allergy Therapeutics's is 1.4031. This would suggest that Allergy Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site